PLANTATION, Fla., Feb. 2, 2006 (PRIMEZONE) -- MEDirect Latino Inc. (Pink Sheets:MLTO) (www.medirectlatino.org), the first national provider of direct-to-consumer Medicare reimbursed medical products focused exclusively on chronic diseases afflicting the Hispanic community, today announced a conference call to be held on Wednesday February 8, 2006 at 4:15 PM Eastern Daylight Time. MEDirect Latino's management team will host the call, in attendance for the Company will be Co-Chairman and CEO, Mr. Raymond Talarico, President, Ms. Debra L. Towsley and COO, Mr. Charles W. Hansen, who will be making presentations on various aspects of the Company's latest results, continuing growth strategies, and expected results for the remainder of the year.
"We are achieving record monthly operating results and are looking forward to discussing these results and our continuing growth strategies with our shareholders, interested brokers and analysts. In order to efficiently handle the increasing customer demand, and maximize the use of our current facility, our plan to add a second shift of customer service, billing and processing staff has now been implemented. With a total of 16 of the anticipated 32 new employees now being deployed on the second shift, we have staff dedicated to meet the growing demand for our products and services from customers in California, Nevada, New Mexico and Arizona." stated, Mr. Hansen. "Our operating results for January, which we will be releasing immediately prior to this call, we believe will clearly show that that our unprecedented growth trend is continuing, if not accelerating."
MEDirect Latino President, Ms. Debra L. Towsley, noted, "Furthering our commitment to provide maximum disclosure and communication to our shareholders and the investment community, we are looking forward to this important conference call. We will also be discussing how the Company is meeting the operating challenges that our growth rate has presented, as well as key personnel that have been added in recent months. We feel that is appropriate at this time to discuss our operating plans, our pending move to reporting status, as well as our plans to move to a more recognized stock exchange, and our plans to maximize shareholder's value in the immediate future."
Interested parties may hear the conference call by telephone.
To hear the conference call as it takes place:
Call 1-800-374-0113 in the United States or Canada or; Call 1-706-758-9607 Internationally
To hear a recording of the call (available immediately following the call by telephone for 30 days):
Call 1-800-642-1687 in the United States or Canada or; Call 1-706-645-9291 Internationally Pin Code: 5020374 followed by the number key
ABOUT MEDIRECT LATINO:
MEDirect Latino (OTC:MLTO) (www.medirectlatino.org) is a rapidly growing, uniquely positioned provider of direct-to-consumer Medicare reimbursed medical products focused exclusively on chronic diseases afflicting the Hispanic community in the United States and Puerto Rico. MEDirect is the only company positioned to serve the U.S. Hispanic healthcare market as a direct-to-consumer Medicare provider on an authentically national level. The Company's current focus is the distribution of products for the treatment of Type II diabetes specifically because of its disproportionate impact and increasing diagnosis rate within the US Hispanic population, noting an incidence of 120% higher than among non-Hispanic whites. Type II diabetes was also targeted because of its unique status within the Medicare reimbursement regime and because of its high degree of correlation to other chronic conditions such as high blood pressure and heart disease. These other conditions represent considerable future market potential that will allow MEDirect to efficiently scale its model by leveraging its existing client base and infrastructure.
The current Hispanic market for MEDirect's products is conservatively estimated at approximately $748MM in the continental United States. The size of the opportunity is understated by such figures as an estimated 1.2 million of the over 4.1 million Hispanics in the United States over 65 eligible to receive Medicare benefits are currently collecting these benefits with an estimate that over 1.4 million of those Medicare-eligible Hispanics have diabetes (implying a potential continental U.S. market for MEDirect products of approximately $1 billion).
The MEDirect Latino Inc. logo is available at:http://www.primezone.com/newsroom/prs/?pkgid=1873
Safe Harbor Disclosure:
This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.